To evaluate the diagnostic accuracy (distress recognition) of the new procedure for detecting psychological distress in patients with cancer
ID
Bron
Verkorte titel
Aandoening
Psychological distress
Cancer patients
Anxiety
Depression
Psychologische distress
Kankerpatiënten
Angst
Depressie
Ondersteuning
PO Box 74077, 1070 BB Amsterdam
PO Box 74077, 1070 BB Amsterdam
Phone: +31.20.788.50.98.
E-mail: f.struijk@ggzingeest.nl
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Primary outcome is the recognition of psychological distress after introduction of the new procedure. The diagnostic accuracy of the new procedure (study aim v-a) is determined by comparing information in the medical/nursing record about the presence of psychological distress with patient reported psychological distress (Distress Thermometer + Problem List, HADS). Sensitivity, specificity, false positives, false negatives, and positive and negative predictive value are determined.
Achtergrond van het onderzoek
With this trial we want to improve psychosocial care for patients with cancer and adequately detect psychological distress in these patients. To achieve this, oncologists and nurses will receive a training aimed at communicating about emotions, including emphatically ending a conversation about emotions, and at targeted referral. Furthermore, based on predefined risk factors, patients will be divided into two groups: (a) patients with a low risk of developing psychological distress, and (b) patients with a high risk of developing psychological distress. Patients at high risk for distress will be monitored closely and care needs will be evaluated regularly. All adult cancer patients will be asked to participate, excluding patients participating in interfering trials, patients who are referred to our hospital for a second opinion and patients with a life expectancy of less than three months.
Doel van het onderzoek
To evaluate the diagnostic accuracy (distress recognition) of the new procedure for detecting psychological distress in patients with cancer
Onderzoeksopzet
3 months after start treatment
Onderzoeksproduct en/of interventie
Based on empirically derived predictors of poor resilience (‘yellow flags’), patients are divided into (I) a group with an elevated risk of experiencing psychological distress, and (II) a group with a normal risk.
Group I
(i) Within group I oncologists and nurses provide basic support in dealing with emotional and mental challenges inherent to illness and treatment, as well as supporting existing resilience and optimizing coping strategies. Training in counseling and supervision are provided to medical and nursing staff.
(ii) The oncologist and oncology nurse are alert to possible psychological distress (case finding): the patient’s psychological state is an explicit topic of conversation. The ‘Lastmeter’ and the PHQ4 are available to facilitate detection of psychological distress.
(iii) In case of psychological distress, the oncologist and/or oncology nurse explores the severity and nature of the problem, using the ‘Lastmeter’. The most appropriate assistance is determined, in deliberation with the patient.
Group II
(i) Within group II oncologists and nurses provide support (analogous to group I).
(ii) Oncologist and nurses rely on the usual approach in regular visits to detect psychological distress. The ‘Lastmeter’ and the PHQ4 are available to facilitate detection of psychological distress.
(iii) The most appropriate assistance is determined (analogous to group I).
Algemeen / deelnemers
Wendy Aerts
Amsterdam 1081 HL
The Netherlands
Tel: 020-7884582
E-mail: w.aerts@ggzingeest.nl
Wetenschappers
Wendy Aerts
Amsterdam 1081 HL
The Netherlands
Tel: 020-7884582
E-mail: w.aerts@ggzingeest.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
• Patients with cancer, treated at the VU University Medical Center (VUmc), department of Medical Oncology (clinic and day treatment)
• Patients are enrolled, using a proportional stratified consecutive sample based on the cancer diagnoses in the population at the department of Medical Oncology. Each stratum is represented in the sample (both in the ‘before’ and ‘after’ phase) in the same proportion as in the population at the department of Medical Oncology
• Start with anti-tumor treatment
• Life expectation > 3 months
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
• Age < 18 or > 85 years
• Second opinion
• Patients with head or neck cancer
• Patients who are participating in the TES-trial
• Insufficient command of the Dutch language
• No informed consent
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5076 |
NTR-old | NTR5208 |
Ander register | VU University Medical Center : 2015.072 |